Zobrazeno 21 - 30
of 98
pro vyhledávání: '"59"'
Publikováno v:
Antimicrobial Agents and Chemotherapy. 62
Data are needed from outpatient settings to better inform antimicrobial stewardship. In this study, a random sample of outpatient antibiotic prescriptions by primary care providers (PCPs) at our health care system was reviewed and compared to consens
Autor:
Larissa V. G. Longo, Fernanda F. M. Cunha, Natanael P. Leitão, Daniel M. Garcia, Antonio C. F. Caires, Denise C. Arruda, Luiz S. Silva, Rosana Puccia, Alisson L. Matsuo, Jhon H. S. Pires, Fernando Real
Publikováno v:
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, 2015, 59 (12), pp.7214-7223. ⟨10.1128/AAC.00512-15⟩
Antimicrobial Agents and Chemotherapy, 2015, 59 (12), pp.7214-7223. ⟨10.1128/AAC.00512-15⟩
Paracoccidioidomycosis (PCM), caused by Paracoccidioides species, is the main cause of death due to systemic mycoses in Brazil and other Latin American countries. Therapeutic options for PCM and other systemic mycoses are limited and time-consuming,
Publikováno v:
Antimicrobial agents and chemotherapy, vol 59, iss 10
Current treatments for cutaneous and visceral leishmaniasis are toxic, expensive, difficult to administer, and limited in efficacy and availability. Disulfiram has primarily been used to treat alcoholism. More recently, it has shown some efficacy as
Autor:
Masaki Yamamoto, Shunji Takakura, Akihiko Hayashi, Yasufumi Matsumura, Harumi Watanabe, Toshiaki Komori, Tsunehiro Shimizu, Shoichi Doi, Naohisa Fujita, Michio Tanaka, Satoshi Ichiyama, Miki Nagao
Publikováno v:
Antimicrobial Agents and Chemotherapy. 59:5107-5113
The efficacy of cefmetazole and flomoxef (CF) for the treatment of patients with extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) bacteremia (ESBL-CF group) was compared with that of carbapenem treatment for ESBL-EC patients (ESBL-
Autor:
Jason W. Chien, Laurel J. Gershwin, Anne Carey, Richard L. Mackman, Eugene J. Eisenberg, Michel Perron, Sandy Lewis, Robert Jordan, Heather A. McEligot, Robert G. Strickley, Mark L Anderson, Nicole E. Behrens, Matt X. Shao, Tomas Cihlar
Publikováno v:
Antimicrobial agents and chemotherapy, vol 59, iss 8
Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and pneumonia in infants. Effective treatment for RSV infection is a significant unmet medical need. While new RSV therapeutics are now in development, there are very few animal
Autor:
Michael A. Lyons
Publikováno v:
Antimicrobial Agents and Chemotherapy. 62
Pretomanid is a nitroimidazole antibiotic in late-phase clinical testing as a component of several novel antituberculosis (anti-TB) regimens. A population pharmacokinetic model for pretomanid was constructed using a Bayesian analysis of data from two
Autor:
de Kock, M, Tarning, J, Workman, L, Allen, EN, Tekete, MM, Djimde, AA, Bell, DJ, Ward, SA, Barnes, KI, Denti, P
Publikováno v:
Antimicrobial Agents and Chemotherapy
Sulfadoxine-pyrimethamine with amodiaquine is recommended by the World Health Organization as seasonal malaria chemoprevention for children aged 3 to 59 months in the sub-Sahel regions of Africa. Suboptimal dosing in children may lead to treatment fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::19503b5971361cb5f6741fcaf245013b
Publikováno v:
Journal of Clinical Microbiology. 56
There has been a resurgence of syphilis diagnoses in Australia. We investigated whether our Treponema pallidum PCR test provides any additional diagnostic information over syphilis serology (chemiluminescence immunoassay [CMIA], Treponema pallidum pa
Autor:
Jay N. Lozier, Jomy M. George, Anela Kellogg, Colleen Hadigan, Khanh Nghiem, Kristina M Brooks, Parag Kumar, Scott R. Penzak, Raul M. Alfaro, Lori A. Gordon, Maryellen McManus
Publikováno v:
Antimicrobial Agents and Chemotherapy. 61
Dabigatran etexilate (DE) is a P-glycoprotein (P-gp) probe substrate, and its active anticoagulant moiety, dabigatran, is a substrate of the multidrug and toxin extrusion protein-1 (MATE-1) transporter. The antiretroviral pharmacokinetic enhancers, r
Autor:
Uwe Hahn, Michael S. Roberts, Jason A. Roberts, Fekade B. Sime, Sandra L. Peake, Jeffrey Lipman, Morgyn S. Warner, Ing Soo Tiong
Changes in the pharmacokinetics of piperacillin in febrile neutropenic patients have been reported to result in suboptimal exposures. This study aimed to develop a population pharmacokinetic model for piperacillin and perform dosing simulation to des
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72531b13416062580d3e9306a7dcc0e7
https://europepmc.org/articles/PMC5655099/
https://europepmc.org/articles/PMC5655099/